Janardan Khandekar to Head and Neck Neoplasms
This is a "connection" page, showing publications Janardan Khandekar has written about Head and Neck Neoplasms.
Connection Strength
0.090
-
Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590). Cancer. 2017 Dec 01; 123(23):4653-4662.
Score: 0.084
-
Metastatic basal cell carcinoma. J Surg Oncol. 1980; 15(2):171-80.
Score: 0.006